近日，厦门证监局对华福证券出具警示函，因其作为主办券商在发行推荐中未勤勉尽责，未能查明厦门 市江平生物基质技术股份有限公司（简称"江平生物"）在定向发行说明书中存在的财务造假情形。 厦门证监局指出，华福证券上述行为违反了《非上市公众公司监督管理办法》，并决定对华福证券采取 出具警示函的监督管理措施。厦门证监局表示，华福证券应充分关注挂牌公司财务内控有效性，健全挂 牌公司持续督导及定向发行推荐业务内控制度，落实勤勉尽责要求，切实提高执业质量水平。 来源：厦门证监局 此前，厦门证监局已对江平生物相关负责人下达了行政监管措施决定书，其中披露有关江平生物财务造 假的具体情况。 | 震引号 | bm56000001/2025-00010790 | 分类 | 行政监管措施行政执法 | | --- | --- | --- | --- | | 发布机构 | | 发文日期 | 2025年09月12日 | | 名称 | 厦门证监局关于对张慧德、祁伟、夏长平、戴燕芳、陈剧、文美、场弦、林明月采取出国警示退盟的决定 | | | | 文 号 | 中国证券监督管理委员会见门监管局行政监管陆线决定书(2025)21号 | 主题词 | | ...

Core Viewpoint - Xiamen Securities Regulatory Bureau issued a warning letter to Huafu Securities for failing to perform due diligence in its role as the sponsor for Jiangping Biological's private placements, leading to undisclosed false information in the company's financial documents [1][3]. Group 1: Regulatory Actions - Huafu Securities was found to have not adequately verified Jiangping Biological's information disclosure and private placement application documents during two fundraising rounds in 2021 and 2022 [2][3]. - The warning letter will be recorded in Huafu Securities' integrity file as part of the regulatory measures taken by the Xiamen Securities Regulatory Bureau [3]. Group 2: Financial Misconduct - Jiangping Biological inflated its reported revenue by CNY 147 million and CNY 152 million for the years 2021 and 2022, respectively, which accounted for 68.62% and 64.87% of the company's disclosed revenues for those years [3]. - The company also inflated its total profit by CNY 589.4 million and CNY 569.1 million for 2021 and 2022, representing 130.43% and 119.77% of the reported total profits for those years [3]. Group 3: Penalties Imposed - The Xiamen Securities Regulatory Bureau imposed a total fine of CNY 12.6 million on Jiangping Biological's former executives, including the chairman, general manager, and other key personnel, for their involvement in the financial misconduct [3].

Core Insights - The article highlights the significant impact of mushroom grass technology in poverty alleviation and ecological restoration, with its application spread to 107 countries globally [1][5]. Group 1: Technology and Application - Mushroom grass technology, developed in the 1980s, utilizes grass instead of wood for cultivating edible and medicinal fungi, becoming a key tool for poverty alleviation [1][4]. - The technology has been successfully implemented in various countries, with a focus on training local farmers and establishing sustainable production models [4][5]. - The research has shifted from solely focusing on edible fungi to exploring the broader applications of mushroom grass, including soil improvement and ecological restoration [7][9]. Group 2: International Collaboration and Education - The team has engaged in international collaborations, such as signing a memorandum of understanding with Universiti Malaya to promote mushroom grass technology in Malaysia [1]. - Educational initiatives include establishing mushroom grass courses in African universities and conducting training programs for local farmers [5][6]. Group 3: Ecological Impact - The cultivation of mushroom grass has shown promising results in desert areas, transforming barren land into green oases and improving soil quality [8][9]. - Research indicates that organic matter content in treated soils has increased by 58.97%, demonstrating the ecological benefits of mushroom grass [9]. Group 4: Future Prospects - The team is exploring new applications for mushroom grass, including its use in textile materials, indicating a potential expansion of the industry [11]. - The growing interest in mushroom grass technology has led to an increase in personnel involved in research and development, with nearly 100 team members currently engaged [11].